Literature DB >> 8963944

Cytochrome P450 and its interactions with the heme biosynthetic pathway.

F De Matteis1, G S Marks.   

Abstract

An important factor in disruption of hepatic heme biosynthesis by porphyrinogenic drugs appears to be interaction with one or several cytochrome P450 isozymes. Clarification of the nature of the interaction between porphyrinogenic drugs and cytochrome P450 isozymes, as well as identification of the isozymes involved, will be helpful in extrapolating the results of animal experimentation to humans. Administration of griseofulvin to mice results in accumulation in the liver of two N-alkylated protoporphyrins (PPs). The major N-alkyl PP, N-griseofulvin PP, which is devoid of ferrochelatase-inhibitory activity, was shown to be the precursor of N-methyl PP, which is a potent ferrochelatase inhibitor. N-Griseofulvin PP was present predominantly as the Nc regioisomer rather than the anticipated NA regioisomer. Progesterone (PG) 6 beta-hydroxylase and androstenedione (AD) 6 beta-hydroxylase, diagnostic markers for cytochrome P450 3A1/2 activity in rat liver, were identified in chick embryo liver. The in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine (4-ethyl DDC) and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone (TTMS) caused inactivation of chick embryo hepatic PG and AD 6 beta-hydroxylases. Ascorbate was shown to inhibit uroporphyrin accumulation in cultures of chick embryos treated with porphyrinogenic drugs and in the livers of an ascorbate-requiring rat strain treated with a porphyrinogenic combination of chemicals. Ascorbate appears to act by inhibiting oxidation of uroporphyrinogen to uroporphyrin. Avian hepatocytes were cultured in 48-well plates and directly assayed within the wells for the activity of 7-ethoxyresorufin O-deethylation (EROD), and for porphyrin and protein concentration by a fluorescence plate reader. Uroporphyrin was the main porphyrin to accumulate in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in chick embryos, pheasants, ducks, and herring gulls; heptacarboxylated porphyrin predominated in turkey hepatocytes. The EROD-inducing potential of complex mixtures of polyhalogenated aromatic hydrocarbons from herring gull eggs was assessed and compared with that of TCDD. A nuclear heme pool appears to regulate the transcription of the cytochrome P450 2B1/2B2 genes in rat liver, by modulating binding of a transcription factor(s) that appears to be involved in the transcriptional activation by phenobarbitone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963944

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  10 in total

1.  Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney.

Authors:  Jimena V Lavandera; Alcira Maria Del Carmen Batlle; Ana María Buzaleh
Journal:  Cell Mol Neurobiol       Date:  2007-08-04       Impact factor: 5.046

2.  Gene-environmental interactions: Lessons from porphyria.

Authors:  Shigeru Sassa
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

3.  Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.

Authors:  Reginald Davies; Arenda Schuurman; Colin R Barker; Bruce Clothier; Tatyana Chernova; Fiona M Higginson; David J Judah; David Dinsdale; Richard E Edwards; Peter Greaves; Timothy W Gant; Andrew G Smith
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Characterization of the hepatic transcriptome following phenobarbital induction in mice with AIP.

Authors:  Brenden Chen; Minghui Wang; Lin Gan; Bin Zhang; Robert J Desnick; Makiko Yasuda
Journal:  Mol Genet Metab       Date:  2019-01-06       Impact factor: 4.797

Review 5.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

6.  5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB).

Authors:  L E Giono; C L Varone; E T Cánepa
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

7.  Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.

Authors:  S Ding; D Yao; Y Y Deeni; B Burchell; C R Wolf; T Friedberg
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

8.  N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity.

Authors:  Jean-Marie Nicolas; Hugues Chanteux; Valérie Mancel; Guy-Marie Dubin; Brigitte Gerin; Ludovicus Staelens; Olympe Depelchin; Sophie Kervyn
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

Review 9.  When less is more: novel mechanisms of iron conservation.

Authors:  Marina Bayeva; Hsiang-Chun Chang; Rongxue Wu; Hossein Ardehali
Journal:  Trends Endocrinol Metab       Date:  2013-08-12       Impact factor: 12.015

Review 10.  The association between chemical-induced porphyria and hepatic cancer.

Authors:  Andrew G Smith; John R Foster
Journal:  Toxicol Res (Camb)       Date:  2018-06-01       Impact factor: 3.524

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.